Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Suzanne Fiorillo

Concepts (122)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma, Kaposi
7
2026
83
1.020
Why?
HIV Infections
14
2026
3215
0.840
Why?
Gastrointestinal Microbiome
5
2026
769
0.580
Why?
HIV Seropositivity
2
2021
118
0.500
Why?
Q Fever
1
2013
5
0.390
Why?
Herpesvirus 8, Human
5
2021
67
0.370
Why?
Prevotella
2
2025
27
0.360
Why?
Mycoses
1
2013
87
0.360
Why?
Pneumococcal Infections
1
2013
104
0.360
Why?
Radiography, Thoracic
1
2013
174
0.360
Why?
Fever
1
2013
322
0.340
Why?
Sexual Behavior
3
2018
490
0.340
Why?
Mass Screening
2
2026
1307
0.320
Why?
Zimbabwe
8
2026
76
0.300
Why?
Counseling
1
2012
406
0.280
Why?
Anti-Retroviral Agents
3
2024
250
0.270
Why?
AIDS-Related Opportunistic Infections
2
2021
130
0.260
Why?
Homosexuality, Male
2
2026
231
0.250
Why?
Lung Neoplasms
3
2026
2675
0.240
Why?
Macrophages, Alveolar
2
2020
377
0.240
Why?
alpha 1-Antichymotrypsin
1
2025
4
0.220
Why?
Tanzania
2
2013
76
0.180
Why?
Anti-HIV Agents
3
2017
914
0.180
Why?
Bronchoalveolar Lavage Fluid
2
2021
642
0.180
Why?
Hexosaminidases
1
2019
17
0.140
Why?
T-Lymphocytes, Regulatory
1
2021
415
0.140
Why?
Diet
1
2026
1273
0.140
Why?
Adult
15
2026
41087
0.130
Why?
Biomarkers, Tumor
1
2025
1339
0.130
Why?
Anti-Inflammatory Agents
1
2020
474
0.120
Why?
Middle Aged
12
2026
36619
0.120
Why?
Inflammation
3
2026
2919
0.120
Why?
Up-Regulation
1
2019
841
0.110
Why?
Insulin-Like Growth Factor I
1
2017
320
0.110
Why?
Male
16
2026
73396
0.110
Why?
Herpesviridae Infections
2
2021
147
0.110
Why?
Sexual and Gender Minorities
1
2018
269
0.100
Why?
International Cooperation
1
2014
193
0.100
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
19
0.100
Why?
Body Composition
1
2017
689
0.100
Why?
Adipose Tissue
1
2017
642
0.090
Why?
HIV-1
5
2021
913
0.090
Why?
HIV Seronegativity
1
2012
28
0.090
Why?
Humans
20
2026
146342
0.090
Why?
DNA, Viral
2
2013
354
0.090
Why?
Vitamin D Deficiency
1
2014
189
0.090
Why?
Universities
1
2014
451
0.090
Why?
Confidentiality
1
2012
82
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
928
0.080
Why?
Female
13
2026
79499
0.080
Why?
Vitamin D
1
2014
402
0.080
Why?
Sexual Partners
1
2012
195
0.080
Why?
RNA, Viral
1
2014
693
0.080
Why?
Aged, 80 and over
2
2013
8391
0.080
Why?
Risk-Taking
1
2012
321
0.070
Why?
Acquired Immunodeficiency Syndrome
1
2010
238
0.070
Why?
Diagnosis, Differential
1
2013
1503
0.070
Why?
Smokers
2
2020
139
0.070
Why?
Plasma
1
2010
222
0.070
Why?
Incidence
2
2013
2936
0.070
Why?
Predictive Value of Tests
1
2013
2113
0.070
Why?
Biomedical Research
1
2014
729
0.060
Why?
Muscle, Skeletal
1
2017
1818
0.060
Why?
Drug Monitoring
1
2010
399
0.060
Why?
Urban Population
2
2026
497
0.060
Why?
Prospective Studies
5
2022
8123
0.060
Why?
Zidovudine
2
2017
75
0.060
Why?
Lamivudine
2
2017
63
0.060
Why?
Aged
4
2013
26432
0.050
Why?
Longitudinal Studies
2
2026
3017
0.050
Why?
Bronchoscopy
1
2026
227
0.050
Why?
Adolescent
3
2013
22557
0.050
Why?
Health Knowledge, Attitudes, Practice
1
2012
1408
0.050
Why?
Antiretroviral Therapy, Highly Active
2
2017
278
0.050
Why?
Feces
1
2025
496
0.050
Why?
Young Adult
3
2019
14330
0.040
Why?
Rural Population
1
2026
677
0.040
Why?
Antigens, Viral
1
2021
186
0.040
Why?
Viral Load
2
2013
526
0.040
Why?
Immunophenotyping
1
2020
324
0.040
Why?
Survival Analysis
2
2014
1378
0.040
Why?
Infant
1
2013
10114
0.040
Why?
Polymerase Chain Reaction
1
2021
1031
0.030
Why?
Prevalence
1
2026
2861
0.030
Why?
Child, Preschool
1
2013
11913
0.030
Why?
Proteomics
1
2025
1203
0.030
Why?
Benzoxazines
1
2017
31
0.030
Why?
Radiography, Abdominal
1
2017
44
0.030
Why?
Cyclopropanes
1
2017
83
0.030
Why?
Case-Control Studies
1
2025
3647
0.030
Why?
Alkynes
1
2017
67
0.030
Why?
Early Detection of Cancer
1
2022
506
0.030
Why?
Anthropometry
1
2017
204
0.030
Why?
Pilot Projects
2
2014
1888
0.030
Why?
Drug Combinations
1
2017
400
0.030
Why?
Life Style
1
2018
496
0.030
Why?
Emtricitabine
1
2017
209
0.030
Why?
Risk Factors
3
2018
10921
0.030
Why?
CD8-Positive T-Lymphocytes
1
2021
931
0.030
Why?
CD4-Positive T-Lymphocytes
1
2021
1150
0.030
Why?
Tenofovir
1
2017
300
0.030
Why?
Organizational Objectives
1
2014
67
0.030
Why?
Dideoxynucleosides
1
2014
27
0.030
Why?
Organizational Policy
1
2014
76
0.030
Why?
Accreditation
1
2014
100
0.030
Why?
Biomarkers
2
2019
4340
0.020
Why?
Africa South of the Sahara
1
2013
56
0.020
Why?
Smoking
1
2020
1486
0.020
Why?
Child
1
2013
22693
0.020
Why?
Cytokines
1
2020
2081
0.020
Why?
United Kingdom
1
2013
377
0.020
Why?
Odds Ratio
1
2014
1077
0.020
Why?
Kaplan-Meier Estimate
1
2013
970
0.020
Why?
Seroepidemiologic Studies
1
2009
171
0.020
Why?
Curriculum
1
2014
1079
0.020
Why?
Lung
1
2020
4122
0.020
Why?
Treatment Outcome
2
2014
11821
0.020
Why?
Tomography, X-Ray Computed
1
2017
2786
0.020
Why?
Disease Progression
1
2014
2867
0.010
Why?
Surveys and Questionnaires
1
2018
6073
0.010
Why?
Comorbidity
1
2009
1665
0.010
Why?
United States
1
2014
16136
0.010
Why?
Fiorillo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)